Voglibose (Basen®, AO-128), One of the Most Important α-Glucosidase Inhibitors

Author(s): Xiaolong Chen, Yuguo Zheng, Yinchu Shen.

Journal Name: Current Medicinal Chemistry

Volume 13 , Issue 1 , 2006

Abstract:

The number of people with diabetes is expected to rise from the current estimated 150 million to 220 million in 2010 and 300 million in 2025, and 90% is Type 2 diabetes or non-insulin dependant diabetes mellitus (NIDDM). Voglibose, one of the most important α-glucosidase inhibitors, delays the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia, and is the aid in the treatment of diabetes. In this paper, properties and the preparation of voglibose are reviewed.

Keywords: Voglibose, Glucosidase inhibitor, Preparation, NIDDM

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 1
Year: 2006
Page: [109 - 116]
Pages: 8
DOI: 10.2174/092986706789803035

Article Metrics

PDF: 38